Jan is the Founding Managing Partner of Valiance. He brings over 20 years of experience in growth investing. He leads the Investment Committee for the Valiance Funds and is responsible for all aspects of the Funds’ investment processes. Jan currently serves on the Board of several Valiance entities funds and portfolio companies including MDxHealth, JenaValve, MyCartis and 4Tech.

Prior to founding Valiance, Jan was CEO of La Fayette, where during his tenure the La Fayette Funds increased in AUM from $750 million to $5.5 billion. Before that, he was responsible for the Permal Group’s European-based investment management and research activities, and prior to that he worked at Lazard in Corporate Finance M&A.

Jan holds a BA in Business Economics from Gent University in Belgium, and a Masters in Banking & Finance from the University of Aix-Marseille, France.

Pepe brings 30 years of business and management experience in the medical device industry and serves on the Board of Lungpacer, FEops, JenaValve, and Laminate.

Pepe joined Valiance from Singapore-based Biosensors where he most recently served as Vice Chairman of the Board of Directors. Pepe started his tenure at Biosensors as Executive Director and CEO. He performed a turn-around of the Company’s operating performance, forged strategic alliances and worked with the largest shareholder to successfully privatise and de-list the company in order to create a global player in interventional cardiology valued at over a $1 billion. Pepe joined Biosensors from Abbott where he was Vice President of Abbott Vascular and led the global commercial introduction of MitraClip, a percutaneous treatment for mitral valve repair. Prior to Abbott he served as Vice President and General Manager of Drug Eluting Stents at Guidant based in California. He started his career at Eli Lily in London.

Pepe holds a BSc in Biomedical and Electrical engineering from the Universidad Politecnica de Madrid, Spain.

Staffan brings over 30 years of business and management experience in the medical devices and the health care industry.

Staffan joined Valiance from Handicare Group,  a company operating in Accessibility and Patient Handling, where he served as President and CEO. Prior, Staffan was Executive VP Global Commercial Operations & Strategy at Molnlycke Health Care where he was responsible for all global sales & marketing activities. In addition, he was responsible for Molnlycke’s strategic portfolio work, clinical and market access departments. Staffan started his career in Health Care at Johnson & Johnson Medical Devices where he performed a number of different positions in Senior Management throughout Europe, Middle East and Africa for a period of +20 years. He was President of Cordis EMEA for six years leading the Cardiology, Endovascular, Neurovascular and Electrophysiology businesses. In his last position with J&J as Regional VP he was responsible for the Global Surgery business where he delivered substantial operational growth and annual profits.

Staffan also serves as Non Executive Board member for Ferrosan Medical Devices, a world leading provider of gelatin-based topical absorbable haemostatic agent products. He is also Chairman of the Board for OnDosis, a Swedish life science start-up developing a new category of drug delivery devices.

Staffan holds a BA degree in Marketing from Gothenburg School of Economics and a degree in Mechanical Engineering from Polhems in Gothenburg.

Paula is an Investment Principal. She brings almost 8 years experience, and 6 years Healthcare experience to the team. 

Paula joined from Silicon Valley Bank, where she focused on bespoke funding and banking solutions, portfolio relationship management and business development for the bank’s EMEA Healthcare clients. These ranged from Series A funded start ups, through to public and corporate profiles, in the digital health, medical devices, diagnostics and biopharma space. 

Most recently she was a Vice President on the EMEA Healthcare credit solutions team, focused on providing a wide range of lending solutions, from venture debt to cash flow, for the credit healthcare portfolio. 

Paula holds a First Class BSc Hons degree in Cell and Molecular Biology from University College Dublin, as well as an MSc in Management from University College London.

Diego is an Investment Analyst, bringing nearly three years of investment banking experience.

Diego joined from the Investment Banking team at J.P. Morgan in London, where he focused on client advisory services relating to M&A, IPOs and equity and debt financing transactions. Previously, he spent a year in investment banking at HSBC.

He holds a MSc in Management from ESCP Business School in Paris, France and a BSc in Business Administration from the University of Florence, Italy.

Harriet is the Chief of Staff at Valiance.

Harriet started her career in the UK Houses of Parliament and spent over 3 years in the House of Commons. She worked her way up to the position of Senior Parliamentary Researcher for a Government Minister whose focus was on business and industrial strategy. She has extensive experience in strategic operational roles in both the House of Commons and Ministerial Private Offices settings. After leaving Parliament, Harriet was an Investor Relations Associate for a leading multi-family office with offices in London and Singapore where she was responsible for client relations, operations and legal support.

Harriet holds a Bachelor of Laws (Hons) degree from King’s College London.

Fern is an Operations Assistant working in the Finance and Operations department, collaborating across all areas of the Valiance portfolio. She brings 6 years of experience across various sectors including FX trading, eCommerce, healthcare, energy and industry.

Fern is an experienced operations and project management professional, focussing on data analysis, digital marketing, supplier relationships, daily business operations, bookkeeping, systems implementation, staff training and events management.